Glucocorticoid therapy and equine laminitis: Fact or fiction?

Equine Veterinary Education

Volumn 16, Issue 2, 2004, Pages 90-93

  Cornelisse, C J ^a   Robinson, N E ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Glucocorticoids; Horse; Laminitis; Triamcinolone acetonide

Indexed keywords

BETAMETHASONE; DEXAMETHASONE; GLUCOCORTICOID; MATRIX METALLOPROTEINASE; METHYLPREDNISOLONE; NITRIC OXIDE; TRIAMCINOLONE ACETONIDE;

CELL DIFFERENTIATION; CELL PROLIFERATION; CHRONIC DRUG ADMINISTRATION; COLLAGEN SYNTHESIS; CORTICOSTEROID THERAPY; CYTOPATHOLOGY; DRUG INDUCED DISEASE; DRUG MEGADOSE; ENZYME ACTIVITY; FOOD AND DRUG ADMINISTRATION; HORSE DISEASE; INFECTION RISK; INFLAMMATORY DISEASE; KERATINOCYTE; LAMINITIS; MOLECULAR DYNAMICS; NONHUMAN; PATHOPHYSIOLOGY; PREVALENCE; REVIEW; RISK ASSESSMENT; RISK FACTOR; TOXICOKINETICS;

EQUIDAE; EQUUS CABALLUS;

EID: 1842734650     PISSN: 09577734     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-3292.2004.tb00273.x     Document Type: Review

References (56)

1. Adair, H.S. 3rd, Goble, D.O., Schmidhammer, J.L. and Shires, G.M. (2000) Laminar microvascular flow, measured by means of laser Doppler flowmetry, during the prodromal stages of black walnut-induced laminitis in horses. Am. J. vet. Res. 61, 862-868.
2. Anon (2002) Adverse Drug Experience Summary, FDA.
3. Baxter, G.M. (1995) Alterations of endothelium-dependent digital vascular responses in horses given low dose endotoxin. Vet. Surg. 24, 87-96.
4. Best, R., Nelson, S.M. and Walker, B.R. (1997) Dexamethasone and 11-dehydrodexamethasone as tools to investigate the isozymes of 11 beta-hydroxysteroid dehydrogenase in vitro and in vivo. J. Endocrinol. 153, 41-48.
5. Cardillo, C., Nambi, S.S., Kilcoyne, C.M., Choucair, W.K., Katz, A., Quon, M.J. and Panza, J.A. (1999) Insulin stimulates both endothelin and nitric oxide activity in the human forearm. Circulation 100, 820-825.
6. Chen, C.L., Sailor, J.A., Collier, J. and Wiegand, J. (1992) Synovial and serum levels of triamcinolone following intra-articular administration of triamcinolone acetonide in the horse. J. vet. Pharmacol. Ther. 15, 240-246.
7. Cogswell, A.M., Johnson, P.J. and Adams, H.R. (1995) Evidence for endothelium-derived relaxing factor/nitric oxide in equine digital arteries. Am. J. vet. Res. 56, 1637-1641.
8. Cripps, P.J. and Eustace, R.A. (1999) Radiological measurements from the feet of normal horses with relevance to laminitis. Equine vet. J. 31, 427-432.
9. Cunningham, F.E., Rogers, S., Fischer, J.H. and Jensen, R.C. (1996) The pharmacokinetics of dexamethasone in the thoroughbred racehorse. J. vet. Pharmacol. Ther. 19, 68-71.
10. Diederich, S., Hanke, B., Burkhardt, P., Muller, M., Schoneshofer, M., Bahr, V. and Oelkers, W. (1998) Metabolism of synthetic corticosteroids by 11 beta-hydroxysteroid-dehydrogenases in man. Steroids 63, 271-277.
11. Dybdal, N.O., Hargreaves, K.M., Madigan, J.E., Gribble, D.H., Kennedy, P.C. and Stabenfeldt, G.H. (1994) Diagnostic testing for pituitary pars intermedia dysfunction in horses. J. Am. vet. med. Ass. 204, 627-632.
12. Eyre, P., Elmes, P.J. and Strickland, S. (1979) Corticosteroid- potentiated vascular responses of the equine digit: a possible pharmacologic basis for laminitis. Am. J. vet. Med. 40, 135-138.
13. Frederick, D.M. and Kehl, M. (2000) Case report: back from the brink. Equus 272, 34-41.
14. French, K., Pollitt, C.C. and Pass, M.A. (2000) Pharmacokinetics and metabolic effects of triamcinolone acetonide and their possible relationships to glucocorticoid-induced laminitis in horses. J. vet. Pharmacol. Ther. 23, 287-292.
15. Frisbie, D.D., Kawcak, C.E., Trotter, G.W., Powers, B.E., Walton, R.M. and McIlwraith, C.W. (1997) Effects of triamcinolone acetonide on an in vivo equine osteochondral fragment exercise model. Equine vet. J. 29, 349-359.
16. Gerber, H. (1970) Nebenwirkungen von kortikosteroid-behandlungen beim grosstier. Schweiz. Arch. Tierheilkd. 112, 51-57.
17. Grosenbaugh, D.A., Hood, D.M., Amoss, M.S. Jr. and Williams, J.D. (1991) Characterisation and distribution of epidermal growth factor receptors in equine hoof wall laminar tissue: comparison of normal horses and horses affected with chronic laminitis. Equine vet. J. 23, 201-206.
18. Haapasaari, K.M., Risteli, J. and Oikarinen, A. (1996) Recovery of human skin collagen synthesis after short-term topical corticosteroid treatment and comparison between young and old subjects. Brit. J. Dermatol. 135, 65-69.
19. Houdeshell, J.W. (1969) Field trials of a new long-acting corticosteroid in the treatment of equine arthropathies. Vet. Med. small Anim. Clin. 64, 782-784.
20. Hunt, R.J. (1993) A retrospective evaluation of laminitis in horses. Equine vet. J. 25, 61-64.
21. Jaffuel, D., Roumestan, C., Balaguer, P., Henriquet, C., Gougat, C., Bousquet, J., Demoly, P. and Mathieu, M. (2001) Correlation between different gene expression assays designed to measure trans-activation potencies of systemic glucocorticoids. Steroids 66, 597-604.
22. Johnson, P.J. (1999) Laminitis, 'hypothyroidism', and obesity: a peripheral cushingoid syndrome in horses. In: Proceedings of the 17th Annual Veterinary Medical Forum, Chicago, Illinois. pp 192-194.
23. Katwa, L.C., Johnson, P.J., Ganjam, V.K., Kreeger, J.M. and Messer, N.T. (1999) Expression of endothelin in equine laminitis. Equine vet. J. 31, 243-247.
24. Korting, H.C., Unholzer, A., Schafer-Korting, M., Tausch, I., Gassmueller, J. and Nietsch, K.H. (2002) Different skin thinning potential of equipotent medium-strength glucocorticoids. Skin Pharmacol. appl Skin Physiol. 15, 85-91.
25. Koupai-Abyazani, M.R., Yu, N., Esaw, B. and Laviolette, B. (1995) Determination of triamcinolone acetonide in equine serum and urine by liquid chromatography-atmospheric pressure ionization mass spectrometry. J. anal. Toxicol. 19, 182-186.
26. Kylmaniemi, M., Oikarinen, A., Oikarinen, K. and Salo, T. (1996) Effects of dexamethasone and cell proliferation on the expression of matrix metalloproteinases in human mucosal normal and malignant cells. J. dent. Res. 75, 919-926.
27. LaPointe, J.-M., Lavoie, J.-P. and Vrins, A.A. (1993) Effects of triamcinolone acetonide on pulmonary function and bronchoalveolar lavage cytologic features in horses with chronic obstructive pulmonary disease. Am. J. vet. Res. 54, 1310-1316.
28. Lepage, O.M., Laverty, S., Marcoux, M. and Dumas, G. (1993) Serum osteocalcin concentration in horses treated with triamcinolone acetonide. Am. J. vet. Res. 54, 1209-1212.
29. Lose, M.P. (1980) Drug-induced laminitis in a colt. Mod. vet. Pract. 61, 608-610.
30. Maddison, J.E. (1994) Adverse drug reactions: report of the Australian Veterinary Association Adverse Drug Reaction Subcommittee, 1993. Aust. vet. J. 71, 53-57.
31. Maddison, J.E. (1996) Adverse drug reactions: report of the Australian Veterinary Association Adverse Drug Reaction Subcommittee, 1994. Aust. vet. J. 73, 132-136.
32. Madlener, M., Parks, W.C. and Werner, S. (1998) Matrix metalloproteinases (MMPs) and their physiological inhibitors (TIMPs) are differentially expressed during excisional skin wound repair. Expt. cell. Res. 242, 201-210.
33. Masuzaki, H., Paterson, J., Shinyama, H., Morton, N.M., Mullins, J.J., Seckl, J.R. and Flier, J.S. (2001) A transgenic model of visceral obesity and the metabolic syndrome. Science 294, 2166-2170.
34. McCluskey, M.J. and Kavenagh, P.B. (2004) Clinical use of triamcinolone acetonide in the horse (205 cases) and the incidence of glucocorticoid-induced laminitis associated with its use. Equine vet. Educ. 16, 86-89.
35. Miller, A., Tulbert, C., Puskar, M. and Busija, D.W. (2002) Enhanced endothelin activity prevents vasodilation to insulin in insulin resistance. Hypertension 40, 78-82.
36. Mungall, B.A., Kyaw-Tanner, M. and Pollitt, C.C. (2001) In vitro evidence for a bacterial pathogenesis of equine laminitis. Vet. Microbiol. 79, 209-223.
37. Muylle, E. and Oyaert, W. (1973) Lung function tests in obstructive pulmonary disease in horses. Equine vet. J. 5, 37-44.
38. Oikarinen, A., Haapasaari, K.M., Sutinen, M. and Tasanen, K. (1998) The molecular basis of glucocorticoid-induced skin atrophy: topical glucocorticoid apparently decreases both collagen synthesis and the corresponding collagen mRNA level in human skin in vivo. Brit. J. Dermatol. 139, 1106-1110.
39. Paulmyer-Lacroix, O., Boullu, S., Oliver, C., Alessi, M.C. and Grino, M. (2002) Expression of the mRNA coding for 11 beta-hydroxysteroid dehydrogenase type 1 in adipose tissue from obese patients: an in situ hybridization study. J. clin. Endocrinol. Metab. 87, 2701-2705.
40. Pollitt, C.C. and Daradka, M. (1998) Equine laminitis basement membrane pathology: loss of type IV collagen, type VII collagen and laminin immunostaining. Equine vet. J., Suppl. 26, 139-144.
41. Robinson, N.E., Jackson, C., Jefcoat, A., Berney, C., Peroni, D. and Derksen, F.J. (2002) Efficacy of three corticosteroids for the treatment of heaves. Equine vet. J. 34, 17-22.
42. Rohdewald, P., Mollman, H.W. and Hochhaus, G. (1986) Affinities of glucocorticoids for glucocorticoid receptors in the human lung. Agents Actions 17, 290-291.
43. Rush, B.R., Raub, E.S., Rhoads, W.S., Matson, C.J., Hakala, J.E. and Gillespie, J.R. (1998) Pulmonary function in horses with recurrent airway obstruction after aerosol and parenteral administration of beclomethasone dipropionate and dexamethasone, respectively. Am. J. vet. Res. 59, 1039-1043.
44. Schimmer, B.P. and Parker, K.L. (1996) Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. In: Goodman and Gilman's The phamacological basis of therapeutics. Eds: J.G. Hardman and L.E. Limbird, McGraw-Hill, New York. pp 1459-1486.
45. Schneider, D.A., Parks, A.H., Eades, S.C. and Tackett, R.L. (1999) Palmar digital vessel relaxation in healthy horses and in horses given carbohydrate. Am. J. vet. Res. 60, 233-239.
46. Severino, C., Brizzi, P., Solinas, A., Secchi, G., Maioli, M. and Tonolo, G. (2002) Low-dose dexamethasone in the rat: a model to study insulin resistance. Am. J. Physiol. Endocrinol. Metab. 283, E367-E373.
47. Slater, M.R., Hood, D.M. and Carter, G.K. (1995) Descriptive epidemiological study of equine laminitis. Equine vet. J. 27, 364-367.
48. Slone, D.E., Purohit, R.C., Ganjam, V.K. and Lowe, J.L. (1983) Sodium retention and cortisol (hydrocortisone) suppression caused by dexamethasone and triamcinolone in equids. Am. J. vet. Res. 44, 280-283.
49. Steinberg, H.O. and Baron, A.D. (2002) Vascular function, insulin resistance and fatty acids. Diabetalogia 45, 623-634.
50. Swanstrom, O.G. and Dawson, H.A. (1974) Intra-articular betasone and depomedrol: a comparative study. Proc. Am. Ass. equine Practnrs. 20, 249-254.
51. Trovati, M. and Anfossi, G. (2002) Influence of insulin and of insulin resistance on platelet and vascular smooth muscle cell function. J. Diabetes Complications 16, 35-40.
52. Tumas, D.B., Hines, M.T., Perryman, L.E., Davis, W.C. and McGuire, T.C. (1994) Corticosteroid immunosuppression and monoclonal antibody-mediated CD5+ T lymphocyte depletion in normal and equine infectious anaemia virus-carrier horses. J. gen. Virol. 75, 959-968.
53. Vernimb, G.D., Van Hoose, L.M. and Hennessey, P.W. (1977) Onset and duration of corticosteroid effect after injection of Betasone for treating equine arthropathies. Results of laboratory and clinical studies. Vet. Med. small Anim. Clin. 72, 241-244.
54. Verschooten, F., Desmet, P., Peremans, K. and Picavet, T. (1990) Navicular disease in the horse: the effect of controlled intrabursal corticoid injection. J. equine vet. Sci. 10, 316-320.
55. Wattle, O.S. (2001) Cytokeratins of the matrices of the chestnut (torus carpeus) and periople in horses with acute laminitis. Am. J. vet. Res. 62, 425-432.
56. Weiss, D.J. (1997) Equine laminitis: a review of recent research. Equine Pract. 19, 16-20.